APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plant Sources Anti Cancer Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plant Sources Anti Cancer Agents Market Outlook and Growth Opportunities 2026

22 December 2025207 pages

Choose your research edition.

Industry ResearchPlant Sources Anti Cancer Agents Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant Sources Anti Cancer Agents Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Plant Sources Anti Cancer Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant Sources Anti Cancer Agents Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant Sources Anti Cancer Agents Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Plant Sources Anti Cancer Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plant Sources Anti Cancer Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plant Sources Anti Cancer Agents market include Yunnan Hande, Pfizer, Hainan Yew Pharm, West-Ward Pharmaceuticals, TAPI (Teva), Taj Pharma, Southpharma, ScinoPharm and Samyang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plant Sources Anti Cancer Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plant Sources Anti Cancer Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plant Sources Anti Cancer Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plant Sources Anti Cancer Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Plant Sources Anti Cancer Agents Segment by Company

Yunnan Hande

Pfizer

Hainan Yew Pharm

West-Ward Pharmaceuticals

TAPI (Teva)

Taj Pharma

Southpharma

ScinoPharm

Samyang

Salius

Polymed

Phyton

Novasep

Jiangsu Yew Biotechnology

Huiang biopharma

Getwell

Fresenius-kabi

Cipla

Actiza Pharmaceutical

Plant Sources Anti Cancer Agents Segment by Type

Paclitaxel

Vinorelbine

Irinotecan

Hydroxycamptothecin

Docetaxel

Other

Plant Sources Anti Cancer Agents Segment by Application

Breast Cancer

Ovarian Cancer

Cervical Cancer

Other

Plant Sources Anti Cancer Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plant Sources Anti Cancer Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plant Sources Anti Cancer Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plant Sources Anti Cancer Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Plant Sources Anti Cancer Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Sources Anti Cancer Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant Sources Anti Cancer Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Sources Anti Cancer Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plant Sources Anti Cancer Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant Sources Anti Cancer Agents industry.

Chapter 3: Detailed analysis of Plant Sources Anti Cancer Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plant Sources Anti Cancer Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plant Sources Anti Cancer Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plant Sources Anti Cancer Agents Industry Trends Table 2. Plant Sources Anti Cancer Agents Industry Drivers Table 3. Plant Sources Anti Cancer Agents Industry Opportunities and Challenges Table 4. Plant Sources Anti Cancer Agents Industry Restraints Table 5. Global Plant Sources Anti Cancer Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plant Sources Anti Cancer Agents Revenue Share by Company (2021-2026) Table 7. Global Plant Sources Anti Cancer Agents Sales Volume by Company (tons) & (2021-2026) Table 8. Global Plant Sources Anti Cancer Agents Sales Volume Share by Company (2021-2026) Table 9. Global Plant Sources Anti Cancer Agents Average Price (US$/kg) of Company (2021-2026) Table 10. Global Plant Sources Anti Cancer Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plant Sources Anti Cancer Agents Key Company Manufacturing Base & Headquarters Table 12. Global Plant Sources Anti Cancer Agents Company, Product Type & Application Table 13. Global Plant Sources Anti Cancer Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plant Sources Anti Cancer Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Paclitaxel Table 18. Significant Companies of Vinorelbine Table 19. Significant Companies of Irinotecan Table 20. Significant Companies of Hydroxycamptothecin Table 21. Significant Companies of Docetaxel Table 22. Significant Companies of Other Table 23. Global Plant Sources Anti Cancer Agents Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 24. Global Plant Sources Anti Cancer Agents Sales Volume by Type (2021-2026) & (tons) Table 25. Global Plant Sources Anti Cancer Agents Sales Volume by Type (2027-2032) & (tons) Table 26. Global Plant Sources Anti Cancer Agents Sales Volume Share by Type (2021-2026) Table 27. Global Plant Sources Anti Cancer Agents Sales Volume Share by Type (2027-2032) Table 28. Global Plant Sources Anti Cancer Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Plant Sources Anti Cancer Agents Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Plant Sources Anti Cancer Agents Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Plant Sources Anti Cancer Agents Sales Value Share by Type (2021-2026) Table 32. Global Plant Sources Anti Cancer Agents Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Breast Cancer Table 34. Significant Companies of Ovarian Cancer Table 35. Significant Companies of Cervical Cancer Table 36. Significant Companies of Other Table 37. Global Plant Sources Anti Cancer Agents Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 38. Global Plant Sources Anti Cancer Agents Sales Volume by Application (2021-2026) & (tons) Table 39. Global Plant Sources Anti Cancer Agents Sales Volume by Application (2027-2032) & (tons) Table 40. Global Plant Sources Anti Cancer Agents Sales Volume Share by Application (2021-2026) Table 41. Global Plant Sources Anti Cancer Agents Sales Volume Share by Application (2027-2032) Table 42. Global Plant Sources Anti Cancer Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Plant Sources Anti Cancer Agents Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Plant Sources Anti Cancer Agents Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Plant Sources Anti Cancer Agents Sales Value Share by Application (2021-2026) Table 46. Global Plant Sources Anti Cancer Agents Sales Value Share by Application (2027-2032) Table 47. Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 48. Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (tons) Table 49. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2026) Table 50. Global Plant Sources Anti Cancer Agents Sales by Region (2027-2032) & (tons) Table 51. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2027-2032) Table 52. Global Plant Sources Anti Cancer Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Plant Sources Anti Cancer Agents Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Plant Sources Anti Cancer Agents Sales Value Share by Region (2021-2026) Table 55. Global Plant Sources Anti Cancer Agents Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Plant Sources Anti Cancer Agents Sales Value Share by Region (2027-2032) Table 57. Global Plant Sources Anti Cancer Agents Market Average Price (US$/kg) by Region (2021-2026) Table 58. Global Plant Sources Anti Cancer Agents Market Average Price (US$/kg) by Region (2027-2032) Table 59. Global Plant Sources Anti Cancer Agents Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 60. Global Plant Sources Anti Cancer Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons) Table 62. Global Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2026) Table 63. Global Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons) Table 64. Global Plant Sources Anti Cancer Agents Sales Market Share by Country (2027-2032) Table 65. Global Plant Sources Anti Cancer Agents Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Plant Sources Anti Cancer Agents Sales Value Market Share by Country (2021-2026) Table 67. Global Plant Sources Anti Cancer Agents Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Plant Sources Anti Cancer Agents Sales Value Market Share by Country (2027-2032) Table 69. Yunnan Hande Company Information Table 70. Yunnan Hande Business Overview Table 71. Yunnan Hande Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio Table 73. Yunnan Hande Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Pfizer Plant Sources Anti Cancer Agents Product Portfolio Table 78. Pfizer Recent Development Table 79. Hainan Yew Pharm Company Information Table 80. Hainan Yew Pharm Business Overview Table 81. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio Table 83. Hainan Yew Pharm Recent Development Table 84. West-Ward Pharmaceuticals Company Information Table 85. West-Ward Pharmaceuticals Business Overview Table 86. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio Table 88. West-Ward Pharmaceuticals Recent Development Table 89. TAPI (Teva) Company Information Table 90. TAPI (Teva) Business Overview Table 91. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio Table 93. TAPI (Teva) Recent Development Table 94. Taj Pharma Company Information Table 95. Taj Pharma Business Overview Table 96. Taj Pharma Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio Table 98. Taj Pharma Recent Development Table 99. Southpharma Company Information Table 100. Southpharma Business Overview Table 101. Southpharma Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Southpharma Plant Sources Anti Cancer Agents Product Portfolio Table 103. Southpharma Recent Development Table 104. ScinoPharm Company Information Table 105. ScinoPharm Business Overview Table 106. ScinoPharm Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio Table 108. ScinoPharm Recent Development Table 109. Samyang Company Information Table 110. Samyang Business Overview Table 111. Samyang Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Samyang Plant Sources Anti Cancer Agents Product Portfolio Table 113. Samyang Recent Development Table 114. Salius Company Information Table 115. Salius Business Overview Table 116. Salius Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 117. Salius Plant Sources Anti Cancer Agents Product Portfolio Table 118. Salius Recent Development Table 119. Polymed Company Information Table 120. Polymed Business Overview Table 121. Polymed Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 122. Polymed Plant Sources Anti Cancer Agents Product Portfolio Table 123. Polymed Recent Development Table 124. Phyton Company Information Table 125. Phyton Business Overview Table 126. Phyton Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 127. Phyton Plant Sources Anti Cancer Agents Product Portfolio Table 128. Phyton Recent Development Table 129. Novasep Company Information Table 130. Novasep Business Overview Table 131. Novasep Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 132. Novasep Plant Sources Anti Cancer Agents Product Portfolio Table 133. Novasep Recent Development Table 134. Jiangsu Yew Biotechnology Company Information Table 135. Jiangsu Yew Biotechnology Business Overview Table 136. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 137. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio Table 138. Jiangsu Yew Biotechnology Recent Development Table 139. Huiang biopharma Company Information Table 140. Huiang biopharma Business Overview Table 141. Huiang biopharma Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 142. Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio Table 143. Huiang biopharma Recent Development Table 144. Getwell Company Information Table 145. Getwell Business Overview Table 146. Getwell Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 147. Getwell Plant Sources Anti Cancer Agents Product Portfolio Table 148. Getwell Recent Development Table 149. Fresenius-kabi Company Information Table 150. Fresenius-kabi Business Overview Table 151. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 152. Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio Table 153. Fresenius-kabi Recent Development Table 154. Cipla Company Information Table 155. Cipla Business Overview Table 156. Cipla Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 157. Cipla Plant Sources Anti Cancer Agents Product Portfolio Table 158. Cipla Recent Development Table 159. Actiza Pharmaceutical Company Information Table 160. Actiza Pharmaceutical Business Overview Table 161. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 162. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio Table 163. Actiza Pharmaceutical Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Plant Sources Anti Cancer Agents Distributors List Table 167. Plant Sources Anti Cancer Agents Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Plant Sources Anti Cancer Agents Product Image Figure 2. Global Plant Sources Anti Cancer Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plant Sources Anti Cancer Agents Sales (2021-2032) & (tons) Figure 5. Global Plant Sources Anti Cancer Agents Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Plant Sources Anti Cancer Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Paclitaxel Image Figure 10. Vinorelbine Image Figure 11. Irinotecan Image Figure 12. Hydroxycamptothecin Image Figure 13. Docetaxel Image Figure 14. Other Image Figure 15. Global Plant Sources Anti Cancer Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 16. Global Plant Sources Anti Cancer Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Plant Sources Anti Cancer Agents Sales Volume Share by Type (2021-2032) Figure 18. Global Plant Sources Anti Cancer Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Plant Sources Anti Cancer Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Plant Sources Anti Cancer Agents Sales Value Share by Type (2021-2032) Figure 21. Breast Cancer Image Figure 22. Ovarian Cancer Image Figure 23. Cervical Cancer Image Figure 24. Other Image Figure 25. Global Plant Sources Anti Cancer Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 26. Global Plant Sources Anti Cancer Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Plant Sources Anti Cancer Agents Sales Volume Share by Application (2021-2032) Figure 28. Global Plant Sources Anti Cancer Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Plant Sources Anti Cancer Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Plant Sources Anti Cancer Agents Sales Value Share by Application (2021-2032) Figure 31. Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 32. Global Plant Sources Anti Cancer Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Plant Sources Anti Cancer Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Plant Sources Anti Cancer Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 36. North America Plant Sources Anti Cancer Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Plant Sources Anti Cancer Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Plant Sources Anti Cancer Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 42. South America Plant Sources Anti Cancer Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Plant Sources Anti Cancer Agents Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Plant Sources Anti Cancer Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Plant Sources Anti Cancer Agents Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Plant Sources Anti Cancer Agents Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Paclitaxel
  • Vinorelbine
  • Irinotecan
  • Hydroxycamptothecin
  • Docetaxel
  • Other
Applications
  • Breast Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Other
Companies covered
  • Yunnan Hande
  • Pfizer
  • Hainan Yew Pharm
  • West-Ward Pharmaceuticals
  • TAPI (Teva)
  • Taj Pharma
  • Southpharma
  • ScinoPharm
  • Samyang
  • Salius
  • Polymed
  • Phyton
  • Novasep
  • Jiangsu Yew Biotechnology
  • Huiang biopharma
  • Getwell
  • Fresenius-kabi
  • Cipla
  • Actiza Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  4. 1.2.2 Global Plant Sources Anti Cancer Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Plant Sources Anti Cancer Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plant Sources Anti Cancer Agents Market Dynamics
  1. 2.1 Plant Sources Anti Cancer Agents Industry Trends
  2. 2.2 Plant Sources Anti Cancer Agents Industry Drivers
  3. 2.3 Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
  4. 2.4 Plant Sources Anti Cancer Agents Industry Restraints
3 Plant Sources Anti Cancer Agents Market by Company
  1. 3.1 Global Plant Sources Anti Cancer Agents Company Revenue Ranking in 2025
  2. 3.2 Global Plant Sources Anti Cancer Agents Revenue by Company (2021-2026)
  3. 3.3 Global Plant Sources Anti Cancer Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Plant Sources Anti Cancer Agents Average Price by Company (2021-2026)
  5. 3.5 Global Plant Sources Anti Cancer Agents Company Ranking (2024-2026)
  6. 3.6 Global Plant Sources Anti Cancer Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Plant Sources Anti Cancer Agents Company Product Type and Application
  8. 3.8 Global Plant Sources Anti Cancer Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plant Sources Anti Cancer Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plant Sources Anti Cancer Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plant Sources Anti Cancer Agents Market by Type
  1. 4.1 Plant Sources Anti Cancer Agents Type Introduction
  2. 4.1.1 Paclitaxel
  3. 4.1.2 Vinorelbine
  4. 4.1.3 Irinotecan
  5. 4.1.4 Hydroxycamptothecin
  6. 4.1.5 Docetaxel
  7. 4.1.6 Other
  8. 4.2 Global Plant Sources Anti Cancer Agents Sales Volume by Type
  9. 4.2.1 Global Plant Sources Anti Cancer Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Plant Sources Anti Cancer Agents Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Plant Sources Anti Cancer Agents Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Plant Sources Anti Cancer Agents Sales Value by Type
  13. 4.3.1 Global Plant Sources Anti Cancer Agents Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Plant Sources Anti Cancer Agents Sales Value by Type (2021-2032)
  15. 4.3.3 Global Plant Sources Anti Cancer Agents Sales Value Share by Type (2021-2032)
5 Plant Sources Anti Cancer Agents Market by Application
  1. 5.1 Plant Sources Anti Cancer Agents Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Other
  6. 5.2 Global Plant Sources Anti Cancer Agents Sales Volume by Application
  7. 5.2.1 Global Plant Sources Anti Cancer Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Plant Sources Anti Cancer Agents Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Plant Sources Anti Cancer Agents Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Plant Sources Anti Cancer Agents Sales Value by Application
  11. 5.3.1 Global Plant Sources Anti Cancer Agents Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Plant Sources Anti Cancer Agents Sales Value by Application (2021-2032)
  13. 5.3.3 Global Plant Sources Anti Cancer Agents Sales Value Share by Application (2021-2032)
6 Plant Sources Anti Cancer Agents Regional Sales and Value Analysis
  1. 6.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plant Sources Anti Cancer Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Plant Sources Anti Cancer Agents Sales by Region (2027-2032)
  5. 6.3 Global Plant Sources Anti Cancer Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plant Sources Anti Cancer Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plant Sources Anti Cancer Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plant Sources Anti Cancer Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Plant Sources Anti Cancer Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  12. 6.6.2 North America Plant Sources Anti Cancer Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Plant Sources Anti Cancer Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plant Sources Anti Cancer Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  21. 6.9.2 South America Plant Sources Anti Cancer Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plant Sources Anti Cancer Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plant Sources Anti Cancer Agents Sales Value Share by Country, 2025 VS 2032
7 Plant Sources Anti Cancer Agents Country-level Sales and Value Analysis
  1. 7.1 Global Plant Sources Anti Cancer Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plant Sources Anti Cancer Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Plant Sources Anti Cancer Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Plant Sources Anti Cancer Agents Sales by Country (2027-2032)
  6. 7.4 Global Plant Sources Anti Cancer Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plant Sources Anti Cancer Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plant Sources Anti Cancer Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plant Sources Anti Cancer Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plant Sources Anti Cancer Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plant Sources Anti Cancer Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Hande
  2. 8.1.1 Yunnan Hande Company Information
  3. 8.1.2 Yunnan Hande Business Overview
  4. 8.1.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
  6. 8.1.5 Yunnan Hande Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hainan Yew Pharm
  14. 8.3.1 Hainan Yew Pharm Company Information
  15. 8.3.2 Hainan Yew Pharm Business Overview
  16. 8.3.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
  18. 8.3.5 Hainan Yew Pharm Recent Developments
  19. 8.4 West-Ward Pharmaceuticals
  20. 8.4.1 West-Ward Pharmaceuticals Company Information
  21. 8.4.2 West-Ward Pharmaceuticals Business Overview
  22. 8.4.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
  24. 8.4.5 West-Ward Pharmaceuticals Recent Developments
  25. 8.5 TAPI (Teva)
  26. 8.5.1 TAPI (Teva) Company Information
  27. 8.5.2 TAPI (Teva) Business Overview
  28. 8.5.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
  30. 8.5.5 TAPI (Teva) Recent Developments
  31. 8.6 Taj Pharma
  32. 8.6.1 Taj Pharma Company Information
  33. 8.6.2 Taj Pharma Business Overview
  34. 8.6.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
  36. 8.6.5 Taj Pharma Recent Developments
  37. 8.7 Southpharma
  38. 8.7.1 Southpharma Company Information
  39. 8.7.2 Southpharma Business Overview
  40. 8.7.3 Southpharma Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio
  42. 8.7.5 Southpharma Recent Developments
  43. 8.8 ScinoPharm
  44. 8.8.1 ScinoPharm Company Information
  45. 8.8.2 ScinoPharm Business Overview
  46. 8.8.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
  48. 8.8.5 ScinoPharm Recent Developments
  49. 8.9 Samyang
  50. 8.9.1 Samyang Company Information
  51. 8.9.2 Samyang Business Overview
  52. 8.9.3 Samyang Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio
  54. 8.9.5 Samyang Recent Developments
  55. 8.10 Salius
  56. 8.10.1 Salius Company Information
  57. 8.10.2 Salius Business Overview
  58. 8.10.3 Salius Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Salius Plant Sources Anti Cancer Agents Product Portfolio
  60. 8.10.5 Salius Recent Developments
  61. 8.11 Polymed
  62. 8.11.1 Polymed Company Information
  63. 8.11.2 Polymed Business Overview
  64. 8.11.3 Polymed Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio
  66. 8.11.5 Polymed Recent Developments
  67. 8.12 Phyton
  68. 8.12.1 Phyton Company Information
  69. 8.12.2 Phyton Business Overview
  70. 8.12.3 Phyton Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio
  72. 8.12.5 Phyton Recent Developments
  73. 8.13 Novasep
  74. 8.13.1 Novasep Company Information
  75. 8.13.2 Novasep Business Overview
  76. 8.13.3 Novasep Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio
  78. 8.13.5 Novasep Recent Developments
  79. 8.14 Jiangsu Yew Biotechnology
  80. 8.14.1 Jiangsu Yew Biotechnology Company Information
  81. 8.14.2 Jiangsu Yew Biotechnology Business Overview
  82. 8.14.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
  84. 8.14.5 Jiangsu Yew Biotechnology Recent Developments
  85. 8.15 Huiang biopharma
  86. 8.15.1 Huiang biopharma Company Information
  87. 8.15.2 Huiang biopharma Business Overview
  88. 8.15.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
  90. 8.15.5 Huiang biopharma Recent Developments
  91. 8.16 Getwell
  92. 8.16.1 Getwell Company Information
  93. 8.16.2 Getwell Business Overview
  94. 8.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio
  96. 8.16.5 Getwell Recent Developments
  97. 8.17 Fresenius-kabi
  98. 8.17.1 Fresenius-kabi Company Information
  99. 8.17.2 Fresenius-kabi Business Overview
  100. 8.17.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
  102. 8.17.5 Fresenius-kabi Recent Developments
  103. 8.18 Cipla
  104. 8.18.1 Cipla Company Information
  105. 8.18.2 Cipla Business Overview
  106. 8.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio
  108. 8.18.5 Cipla Recent Developments
  109. 8.19 Actiza Pharmaceutical
  110. 8.19.1 Actiza Pharmaceutical Company Information
  111. 8.19.2 Actiza Pharmaceutical Business Overview
  112. 8.19.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
  114. 8.19.5 Actiza Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plant Sources Anti Cancer Agents Value Chain Analysis
  2. 9.1.1 Plant Sources Anti Cancer Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plant Sources Anti Cancer Agents Sales Mode & Process
  6. 9.2 Plant Sources Anti Cancer Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plant Sources Anti Cancer Agents Distributors
  9. 9.2.3 Plant Sources Anti Cancer Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst